10-Q quarterly report · filed Nov 4, 2026

Option Care Health, Inc. (OPCH) Q3 2026 10-Q Quarterly Report

Short answer

Option Care Health, Inc. (OPCH) filed its Q3 2026 10-Q quarterly report on Nov 4, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $1.5B (up 4.1% year over year) with net income of $57M.

Q3 2026 key financials · XBRL

Revenue
$1.5B
+4.1% YoY · +3.5% QoQ
Net income
$57M
+10.8% YoY · +6.5% QoQ
Operating margin
6.0%
Gross margin
19.1%
EPS (diluted)
$0.38
+18.8% YoY · +8.6% QoQ

Source: XBRL data from the Option Care Health, Inc. (OPCH) Q3 2026 10-Q on SEC EDGAR. USD.

Option Care Health, Inc. Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Q3 revenue $1,493.5M, up 4.1% from $1,435.0M YoY, driven by acute therapy growth
  • Gross margin 19.1% vs 19.0% YoY; operating margin 6.0% vs 5.9%
  • Acute therapies best performer, high-single-digit growth; CID weakest, declining from attrition and unfavorable mix
  • Operating cash flow $286.2M vs $222.6M; cash $299.1M vs $232.6M at December 31, 2025
  • CID headwinds expected to reduce 2026 gross profit by approximately $55M; merger expected to close first half of 2027

Risk Factors

  • Newly added merger risk: October 5, 2026 Merger Agreement created approval and closing uncertainties
  • Regulatory risk: HSR Act and healthcare regulatory approvals could delay or prevent consummation
  • Operational risk: Merger restrictions may limit debt, acquisitions, capital expenditures, and material contracts
  • Financial risk: Termination under specified circumstances could require approximately $145.96 million payment
  • Legal risk: Stockholder litigation could enjoin or delay the Merger and divert management attention

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Option Care Health, Inc. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.